Latest clinical updates | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Clinical

Xevudy (sotrovimab) approved by MHRA for mild to moderate COVID-19

Xevudy (sotrovimab) approved by MHRA for mild to moderate COVID-19

Button battery ingestion in children: A growing problem

Button battery ingestion in children: A growing problem

RAAS inhibition reduces COVID-19 mortality within intensive care

RAAS inhibition reduces COVID-19 mortality within intensive care

World AIDS Day seeks to end inequality

World AIDS Day seeks to end inequality

Analysis shows skin peanut allergy patch safe and well tolerated over 3-year period

Analysis shows skin peanut allergy patch safe and well tolerated over 3-year period

Topical asivatrep, a TRPVI antagonist, effective for adults with atopic eczema

Topical asivatrep, a TRPVI antagonist, effective for adults with atopic eczema

Comirnaty COVID-19 vaccine approved by EMA for children aged 5 – 11

Comirnaty COVID-19 vaccine approved by EMA for children aged 5 – 11

Total bile acid concentration a possible biomarker for coronary artery disease

Total bile acid concentration a possible biomarker for coronary artery disease

Aspirin use linked to increased risk of heart failure

Aspirin use linked to increased risk of heart failure

Metformin use in pre-diabetics with a BMI > 35 reduced incident cardiovascular disease

Metformin use in pre-diabetics with a BMI > 35 reduced incident cardiovascular disease

$Sacubitril-valsartan provides no mortality benefit compared with ramipril in acute MI with reduced ejection fraction$

Sacubitril-valsartan provides no mortality benefit compared with ramipril in acute MI with reduced ejection fraction

Byannli approved by EMA for twice-yearly dosing in schizophrenia

Byannli approved by EMA for twice-yearly dosing in schizophrenia

Strong opiates equivalent to paracetamol and codeine for post-orthopaedic surgery pain

Strong opiates equivalent to paracetamol and codeine for post-orthopaedic surgery pain

Haematological cancer patients at increased risk of severe breakthrough COVID-19 infections

Haematological cancer patients at increased risk of severe breakthrough COVID-19 infections

Risankizumab approved by EMA for active psoriatic arthritis

Risankizumab approved by EMA for active psoriatic arthritis

Cancer diagnoses in young people fell but ICU admissions increased during first wave of pandemic

Cancer diagnoses in young people fell but ICU admissions increased during first wave of pandemic

Atezolizumab and nivolumab prolong overall survival compared with docetaxel in NSCLC

Atezolizumab and nivolumab prolong overall survival compared with docetaxel in NSCLC

HRT use increases risk of disease recurrence in breast cancer survivors

HRT use increases risk of disease recurrence in breast cancer survivors

x